Lauren Biscaldi is the Managing Editor of Drug Topics.
Q&A: Understanding Benefits, Managing Adverse Effects of GLP-1 Receptor Agonists
These therapies are highly beneficial, but can come with a host of gastrointestinal adverse effects that patients may not be prepared to manage alone.
Managing “Class Action” Adverse Effects Crucial for GLP-1 Medication Adherence
Some patients may have difficulty managing the gastrointestinal adverse effects associated with GLP-1 therapies.
Benefits of GLP-1s Transcend Simple Weight Loss for Individuals With Overweight, Obesity, and Comorbidities
Losing even 5% of body weight can improve comorbid conditions and other health complications for individuals with overweight and obesity.
Pfizer Hemophilia A Candidate Shows Positive Topline Results
Data will be discussed with regulatory authorities “in the coming months.”
Efanesoctocog alfa Prophylaxis Offers “Efficacious Prevention” to Children With Severe Hemophilia A
The drug was FDA approved as antihemophilic factor (recombinant), Fc-VWF-XTEN Fusion Protein-ehtl (Altuviiio) in February 2023.
With FDA Approval, Vonoprozan Offers Options for Nonerosive GERD
The approval offers a first of its kind treatment option for patients living with nonerosive GERD.
Amidst Uptick in Cases, Investigational Lyme Disease Vaccine Trial Underway
All participants in the phase 3 clinical trial have completed their primary vaccination series.
FDA, FTC Issue Warnings to Companies Selling Copycat Food Products Containing Delta-8 THC
The companies are marketing products that may violate Federal Trade Commission prohibition of “unfair and deceptive acts in the marketplace.”
COVID-19 Cases Rise as Omicron-Derived FLiRT, LB.1 Variants Take Hold
Updated vaccines are expected to be available in the coming months.
Pfizer Advances Oral GLP-1 Development as the Race for Second-Gen Obesity Therapies Continues
Pfizer joins Eli Lilly and Novo Nordisk in the development of oral GLP-1 receptor agonist candidates.
CGRP Monoclonal Antibody May Reduce Flushing, Chronic Erythema in Rosacea
Calcitonin gene-related peptides are known to trigger vasodilation and inflammation.
Third Ustekinumab Biosimilar Gains FDA Approval
Ustekinumab-ttwe, a biosimilar to ustekinumab (Stelara) is expected launch in the US in February 2025.
Phase 1/2 Trial of Investigational Herpes Zoster Vaccine Candidate Underway
Researchers are evaluating the safety, tolerability, and immunogenicity of shingles vaccine candidate Z-1018.
Head to Head Comparison of GLP-1 RAs for Weight Loss Tips Scales in Tirzepatide’s Favor
Previously, data from head-to-head trials of tirzepatide and semaglutide were not available.
Maternal RSV Vaccination Not Associated With Increased Preterm Birth Risk
Current recommendations suggest women receive the RSV vaccine between 32 and 36 weeks' gestational age.
Survey: Dry Eye Is Common, But Americans Remain Uneducated About the Condition
Results of a new survey show that individuals with dry eye believe the condition is something “people must learn to live with.”
FDA Approves Donanemab (Kisunla) For Early Symptomatic Alzheimer Disease
Donanemab-azbt was approved under the FDA's Fast Track Review, Priority Review, and Breakthrough Therapy designations.
CDC, ACIP Announce Vaccine Recommendations and Updates
The updates follow the Advisory Committee for Immunization Practice meeting held June 26 to 28, 2024.
Check Your Work: Understanding Migraine Therapies
Dive in and learn more about the answers to yesterday’s quiz.
CDC, Partners Mark National HIV Testing Day
The theme of this year’s National HIV Testing Day encourages individuals to self-test for HIV as a means of demonstrating their compassion for themselves.
Quiz: Understanding Migraine Therapies
Test your knowledge of migraine therapies.
Slideshow: Continuous Glucose Monitoring in Type 2 Diabetes
A selection of studies presented at the American Diabetes Association 84th Scientific Sessions examined the use of CGM technology in type 2 diabetes.
CDC: Dengue Virus Poses Increased Threat in United States
Cases of Dengue virus—the most common global arboviral disease—are on the rise.
Self-Management, Education Key to Improving Outcomes in T1D and T2D
Access to diabetes self-management education and support services are crucial for improving diabetes outcomes.
GLP-1s, SGLT2s, and Oral Hypoglycemic Agents: Diabetes Treatment Options
Check out some of the latest research into diabetes medication options.
Teva Pharmaceuticals Launches Liraglutide Injection 1.8 mg, First Generic GLP-1 in the US
The Victoza generic is approved for use in adults and children aged 10 years and older.
Check Your Work: How Much Do You Know About Migraine Triggers?
Quiz: How Much Do You Know About Migraine Triggers?
Test your knowledge of different migraine triggers.
Positive Topline Results for Lumateperone As Adjunctive Therapy for MDD Announced
Two phase 3 clinical trials form the basis of a supplemental New Drug Application for this indication.
FDA Approves Pneumococcal 21-Valent Conjugate Vaccine Capvaxive
The vaccine covers 8 serotypes not currently covered by any FDA-approved pneumococcal vaccines.